
Karuna Therapeutics KRTX
Geschäftsbericht 2023
hinzugefügt 22.02.2024
Karuna Therapeutics ROE 2011-2026 | KRTX
ROE Jährlich Karuna Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -34.58 | -24.54 | -28.64 | -20.23 | -11.27 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -11.27 | -34.58 | -23.85 |
ROE Vierteljährlich Karuna Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29.33 | -26.83 | -35.58 | -35.35 | -45.18 | -48.5 | -38.63 | -21.18 | -26.74 | -22.47 | -21.36 | -13.14 | -15.46 | -12.22 | -11.07 | -9.28 | 11.57 | 34.73 | 40.42 | 37.97 | 37.97 | 17.12 | 15.32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.42 | -48.5 | -9.45 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
Black Diamond Therapeutics
BDTX
|
-83.66 | $ 2.38 | -3.64 % | $ 131 M | ||
|
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
-185.15 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
Alector
ALEC
|
-466.34 | $ 2.1 | -13.79 % | $ 216 M | ||
|
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
-115.61 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Aptose Biosciences
APTO
|
559.76 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Athira Pharma
ATHA
|
-216.19 | - | - | $ 269 M | ||
|
Aridis Pharmaceuticals
ARDS
|
125.33 | - | 17.91 % | $ 11.1 M | ||
|
Altimmune
ALT
|
-76.97 | $ 4.2 | -2.67 % | $ 298 M | ||
|
Arena Pharmaceuticals
ARNA
|
-91.56 | - | -6.81 % | $ 3.04 B | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Avenue Therapeutics
ATXI
|
-418.16 | - | -52.27 % | $ 4.45 M | ||
|
Athersys
ATHX
|
-531.22 | - | 3.77 % | $ 22.4 M | ||
|
Axcella Health
AXLA
|
-1949.71 | - | -16.42 % | $ 249 M | ||
|
AstraZeneca PLC
AZN
|
20.44 | - | - | $ 96.9 B | ||
|
AVEO Pharmaceuticals
AVEO
|
-116.29 | - | - | $ 521 M | ||
|
Atreca
BCEL
|
-123.92 | - | -11.76 % | $ 5.79 M | ||
|
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | ||
|
Apellis Pharmaceuticals
APLS
|
6.05 | $ 20.61 | -1.67 % | $ 2.6 B | ||
|
Agenus
AGEN
|
160.57 | $ 3.33 | - | $ 1.19 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Agios Pharmaceuticals
AGIO
|
-34.6 | $ 28.87 | -4.5 % | $ 1.67 B | ||
|
bluebird bio
BLUE
|
-108.93 | - | - | $ 546 M | ||
|
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M |